Trytosaveabit commented on a stock · Feb 6 06:27

Update

$Alterity Therapeutics(ATHE.US)$ Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
Benzinga· just

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2827 Views

Comment

Trytosaveabit

1794Followers

29Following

21KVisitors